Western blot analysis revealed that deficient expression of CXCL14 in CAFs failed to increase the expression of ERCC4 and inhibited DNA damage-induced apoptosis in bladder cancer cells (Fig. 3J, M). The gene discussed is CXCL14; the disease is urinary bladder cancer.